Evaluation of aspirin use for primary prevention in diabetic patients

Ann Pharmacother. 2015 Jan;49(1):150-1. doi: 10.1177/1060028014561083.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Male
  • Platelet Aggregation Inhibitors / therapeutic use*

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin